Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stroke and T-cells.

Thiruma V Arumugam1, D Neil Granger, Mark P Mattson

  • 1Laboratory of Neurosciences, National Institute on Aging Intramural Research Program, Baltimore, MD 21224, USA. arumugamt@mail.nih.gov

Neuromolecular Medicine
|October 26, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeting the AnxA1/Fpr2/ALX pathway regulates neutrophil function, promoting thromboinflammation resolution in sickle cell disease.

Blood·2021
Same author

Novel Role for the AnxA1-Fpr2/ALX Signaling Axis as a Key Regulator of Platelet Function to Promote Resolution of Inflammation.

Circulation·2019
Same author

Novel Role of T Cells and IL-6 (Interleukin-6) in Angiotensin II-Induced Microvascular Dysfunction.

Hypertension (Dallas, Tex. : 1979)·2019
Same author

A critical role for both CD40 and VLA5 in angiotensin II-mediated thrombosis and inflammation.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2018
Same author

Inhibition of CD147 (Cluster of Differentiation 147) Ameliorates Acute Ischemic Stroke in Mice by Reducing Thromboinflammation.

Stroke·2017
Same author

Reperfusion therapy-What's with the obstructed, leaky and broken capillaries?

Pathophysiology : the official journal of the International Society for Pathophysiology·2017
Same journal

Near‑Infrared Photobiomodulation in White‑Matter Disease: From Microglial States to Measurable Endpoints.

Neuromolecular medicine·2026
Same journal

<sup>64</sup>Cu Hypoxia Imaging Radiotracer Targeting the Human Copper Transporter.

Neuromolecular medicine·2026
Same journal

Curculigoside Alleviates CSDS-induced Depressive-like Behavior by Modulating Pyramidal Neuron Excitability and Synaptic Transmission.

Neuromolecular medicine·2026
Same journal

Association of Cathepsin Proteins with Alzheimer's Disease Risk: An Integrated Observational and Genetic Analysis.

Neuromolecular medicine·2026
Same journal

Single-cell Transcriptomics Reveals that the SORBS1/FBXO22/BAG3 Axis Drives Astrocyte Senescence via Calcium Signaling and Affects Alzheimer's Disease-Related Neuronal Damage.

Neuromolecular medicine·2026
Same journal

Subgroup-Specific Associations of GRIA Genes Encoding AMPA Glutamate Receptor Subunits with Patient Survival in Medulloblastoma.

Neuromolecular medicine·2026
See all related articles

T-cells accumulate in the brain after ischemic stroke, contributing to injury. Therapeutic strategies targeting T-cells require careful design to balance harmful and protective effects.

Area of Science:

  • Neuroimmunology
  • Stroke Pathophysiology

Background:

  • Stroke triggers neuroinflammation, activating brain microvasculature.
  • Leukocyte recruitment, including T-lymphocytes, occurs in post-ischemic brain regions.
  • T-cells are increasingly recognized for their role in ischemic stroke pathogenesis.

Purpose of the Study:

  • To explore the role of T-lymphocytes in ischemic brain injury.
  • To investigate the mechanisms of T-cell recruitment and function in stroke.
  • To evaluate T-cells as potential therapeutic targets for stroke.

Main Methods:

  • Analysis of T-cell accumulation in post-ischemic brain.
  • Investigation of endothelial cell activation and adhesion molecule expression.
  • Examination of cytotoxic CD8+ T-cells and CD4+ T-helper cell subsets (TH1 and TH2).

Related Experiment Videos

Main Results:

  • T-cell recruitment to the brain is dependent on endothelial adhesion molecules.
  • Cytotoxic CD8+ T-cells may directly induce brain injury.
  • Pro-inflammatory TH1 cells contribute to stroke pathogenesis, while anti-inflammatory TH2 cells may be protective.

Conclusions:

  • T-cells are critical players in ischemic stroke, with distinct roles for different subsets.
  • Targeting T-cells offers a potential therapeutic avenue for stroke.
  • Stroke treatments must carefully modulate T-cell activity to mitigate damage and enhance protection, considering infection risks.